Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Gut|June 1, 1994
Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequenceR H Hardwick, N A Shepherd, M Moorghen, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|November 1, 1991
Organ culture as a model for investigating the effects of antimetabolites and nucleoside transport inhibitors on rodent colonic mucosaM Moorghen, P Ince, K J Finney, et al.
Anticancer Research|May 1, 1990
Epidermal growth factor receptors in colorectal carcinomaM Moorghen, P Ince, K J Finney, et al.
British Journal of Cancer|July 1, 1993
TGF-beta expression in the human colon: differential immunostaining along crypt epitheliumA Avery, C Paraskeva, P Hall, et al.
Cell Proliferation|September 24, 1998
Sulindac enhances cell proliferation in DMH-treated mouse colonic mucosaM Moorghen, M Orde, K J Finney, et al.
British Journal of Cancer|February 24, 2001
Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cellsM Guy, M Moorghen, J A Bond, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 21, 2020
MUTYH-associated polyposis - colorectal phenotype and managementR Patel, P McGinty, V Cuthill, et al.
The British Journal of Surgery|May 12, 2016
Outcomes following laparoscopic rectal cancer resection by supervised traineesA C Currie, I White, G Malietzis, et al.
Annals of Clinical Biochemistry|July 21, 2000
Cost-effective strategy for the serological investigation of coeliac diseaseA Bowron, M Moorghen, J E Morgan, et al.
Cell Proliferation|September 20, 2007
Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapyN Banu, A Buda, S Chell, et al.
Pageof 4